UBS Group’s Calpine Corporation CPN Stock Holding History

UBS Group’s Portfolio CPN Stock Details CPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,000,000	Closed	-$13.5M	–	8251
2017 Q2	$13.5M	Buy	1,000,000 +882,000	+747%	+$10.6M	0.01%	1299
2017 Q1	$1.3M	Buy	+118,000	New	+$1.35M	﹤0.01%	3322
2016 Q1	–	Sell	-342,200	Closed	-$4.95M	–	8555
2015 Q4	$4.95M	Sell	342,200 -1,354,300	-80%	-$19.8M	﹤0.01%	1975
2015 Q3	$24.8M	Buy	1,696,500 +1,581,500	+1,375%	+$26M	0.02%	768
2015 Q2	$2.07M	Buy	+115,000	New	+$2.4M	﹤0.01%	2947
2015 Q1	–	Sell	-51,100	Closed	-$1.13M	–	9776
2014 Q4	$1.13M	Buy	+51,100	New	+$1.13M	﹤0.01%	3474

Other funds holding CPN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's CPN Position: Q1 2018 in Review

UBS Group sold out of Calpine Corporation (CPN) in Q1 2018, closing a stake of 1,279,254 shares — an estimated $19.4M sold.

UBS Group first reported a position in CPN in Q4 2014 and held it in 13 quarters. The position peaked at $45.7M in Q3 2015. 1 fund tracked by Wall St. Rank holds CPN as of Q1 2018.

UBS Group reported no remaining Calpine Corporation position as of Q1 2018 after selling out during the quarter.
UBS Group sold 1,279,254 Calpine Corporation shares in Q1 2018, an estimated $19.4M.
UBS Group first reported a position in Calpine Corporation in Q4 2014 and held it in 13 quarters.
UBS Group's Calpine Corporation position peaked at $45.7M in Q3 2015.
1 fund tracked by Wall St. Rank held Calpine Corporation as of Q1 2018.

Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.